Safety, Tolerability, and Antiviral Activity of 24 or 48 Weeks of GS-9190 in Combination With Peginterferon Alfa 2a and Ribavirin for the Treatment of Genotype-1 Chronic HCV Infection
Public ClinicalTrials.gov record NCT00743795. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Trial Comparing 24 or 48 Weeks of GS 9190, in Combination With Peginterferon Alfa 2a and Ribavirin, to 48 Weeks of Peginterferon Alfa 2a and Ribavirin for the Treatment of Genotype-1 Chronic Hepatitis C Virus (HCV) Infection (GS-US-196-0103)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare the safety, tolerability and effectiveness of the experimental drug GS-9190 when administered for 24 or 48 weeks with peginterferon alfa 2a and ribavirin for the treatment of genotype-1 chronic hepatitis C infection.
Study identification
- NCT ID
- NCT00743795
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 252 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2008 (Type not available)
- Primary completion
- Jul 2009 (Actual)
- Completion
- Sep 2013 (Actual)
- Last update posted
- Nov 5, 2013
2008 – 2013
United States locations
- U.S. sites
- 48
- U.S. states
- 20
- U.S. cities
- 40
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Anaheim | California | 92801 | — |
| Not listed | Los Angeles | California | 90048 | — |
| Not listed | Newport Beach | California | 92663 | — |
| Not listed | San Clemente | California | 92673 | — |
| Not listed | San Diego | California | 92115 | — |
| Not listed | San Diego | California | 92123 | — |
| Not listed | San Francisco | California | 94115 | — |
| Not listed | Englewood | Colorado | 80110 | — |
| Not listed | Miami | Florida | 33136 | — |
| Not listed | North Miami Beach | Florida | 33162 | — |
| Not listed | Orlando | Florida | 32803 | — |
| Not listed | Sarasota | Florida | 34243 | — |
| Not listed | Tampa | Florida | 33613 | — |
| Not listed | Atlanta | Georgia | 30308 | — |
| Not listed | Decatur | Georgia | 30033 | — |
| Not listed | Chicago | Illinois | 60611 | — |
| Not listed | Bowling Green | Kentucky | 42101 | — |
| Not listed | Baton Rouge | Louisiana | 70809 | — |
| Not listed | Baltimore | Maryland | 21201 | — |
| Not listed | Baltimore | Maryland | 21229 | — |
| Not listed | Baltimore | Maryland | 21287 | — |
| Not listed | Boston | Massachusetts | 02114 | — |
| Not listed | Detroit | Michigan | 48202 | — |
| Not listed | St Louis | Missouri | 63104 | — |
| Not listed | Cedar Knolls | New Jersey | 07927 | — |
| Not listed | Johnson City | New York | 13790 | — |
| Not listed | New York | New York | 10016 | — |
| Not listed | New York | New York | 10021 | — |
| Not listed | New York | New York | 10029-6574 | — |
| Not listed | New York | New York | 10032 | — |
| Not listed | Plainview | New York | 11803 | — |
| Not listed | Syracuse | New York | 13210 | — |
| Not listed | Asheville | North Carolina | 28801 | — |
| Not listed | Durham | North Carolina | 27710 | — |
| Not listed | High Point | North Carolina | 27262 | — |
| Not listed | Cincinnati | Ohio | 45219 | — |
| Not listed | Cincinnati | Ohio | 45267 | — |
| Not listed | Tulsa | Oklahoma | 74104 | — |
| Not listed | Philadelphia | Pennsylvania | 19104 | — |
| Not listed | Philadelphia | Pennsylvania | 19140 | — |
| Not listed | Germantown | Tennessee | 38138 | — |
| Not listed | Dallas | Texas | 75208 | — |
| Not listed | Houston | Texas | 77090 | — |
| Not listed | San Antonio | Texas | 78215 | — |
| Not listed | Annandale | Virginia | 22003-6800 | — |
| Not listed | Fairfax | Virginia | 22031 | — |
| Not listed | Norfolk | Virginia | 23502-3927 | — |
| Not listed | Richmond | Virginia | 23298 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00743795, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 5, 2013 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00743795 live on ClinicalTrials.gov.